Selected Publications

Andrew M Freddo 1, Humera Ahmed 2, Jonathan B Edelson 2, Juan M Ortega-Legaspi 3, Sumeet Vaikunth 2 3: Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation. Pediatr Cardiol . November 12 2024 Notes: doi: 10.1007/s00246-024-03700-9. Online ahead of print.

James W Schurr 1, Adrian Pearson 1, Matthew S Delfiner 1, Alyson Brown 1, Mary Frances Quinn 2, Yoav Karpenshif 1, Juan Ortega-Legaspi 1, Aditya Parikh 1, Marisa Cevasco 3, Joyce W Wald 1: Hemodynamic Support With the Impella 5.5 Acute Mechanical Circulatory Support Device. ASAIO J October 15 2024 Notes: doi: 10.1097/MAT.0000000000002331. Online ahead of print.

Vaikunth SS, Ortega-Legaspi JM, Conrad DR, Chen S, Daugherty T, Haeffele CL, Teuteberg J, Mclean R, MacArthur JW, Woo YJ, Maeda K, Ma M, Nasirov T, Hoteit M, Hilscher MB, Wald J, Mandelbaum T, Olthoff KM, Abt PL, Atluri P, Cevasco M, Mavroudis CD, Fuller S, Lui GK, Kim YY: Mortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study. Clin Transplant 38(4): e15302, Apr 2024.

Shingina A, Bansal N, Cedars A, Chen S, Daugherty T, Emamaullee J, Ganger D, Ge J, Heller T, Hughes D, Kay J, Ortega Legaspi J, Menachem J, Montenovo M, Sack J, Reardon L, Schiano T, Simpson K, Teuteberg J, Tompkins R, Vodkin I, Wu F, Lui G, Zaidi AN, Kappus M, Hilscher M. : Combined heart liver transplantation in the patients with advanced liver disease and/or hepatocellular carcinoma: Why cannot liver pull the heart? Am J Transplant 24(3): 503-505. Mar 2024.

Lerman JB, Green CL, Molina MR, Maharaj V, Ortega-Legaspi JM, Sen S, Flattery M, Maziarz EK, Shah KB, Martin CM, Alexy T, Shah P, Morris AA, DeVore AD, Cole RT: Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation. Clin Transplant 37(10): e15065, Oct 2023.

Vaikunth S, Sundaravel S, Saef J, Ortega-Legaspi J: Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices. Curr Heart Fail Rep 20(5): 401-416, Oct 2023.

Durgin JS, Jariwala NN, Rook AH, Ortega-Legaspi JM.: Reversible Cardiomyopathy after Interferon-Gamma for Cutaneous T Cell Lymphoma: A Report of Two Cases. Current Problems in Cancer: Case Reports 11, Sep 2023.

Saef J, Sundaravel S, Ortega-Legaspi J, Vaikunth S: Safety and Treatment Experience with Sodium/glucose Cotransporter-2 Inhibitors (SGLT2i) in Adult Patients with Congenital Heart Disease. J Card Fail 29(6): 974-975, Jun 2023.

Ortega-Legaspi JM, Molina M, Leon J, Cunningham A, Guerraty M, Peyster E, Julien H, McLean R, Goldberg L, Bravo PE: Coronary Flow Reserve is an Independent Predictor of Major Adverse Cardiovascular Events in Long Term Heart Transplantation Survivors. The Journal of Heart and Lung Transplantation Apr 2023 Notes: Presented at 2023 ISHLT annual meeting, Denver, CO.

Juan M Ortega-Legaspi: Miocardiopatias. Cardiologia para medicos no especialistas. Ursulo Juarez Herrera (eds.). PyDESA, 2023.